Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Felodipine; Ramipril
IMED Healthcare Ltd.
C09BB; C09BB05
Felodipine; Ramipril
5/5 mg/mg
Prolonged-release tablet
Product subject to prescription which may be renewed (B)
ACE inhibitors and calcium channel blockers; ramipril and felodipine
Authorised
2014-08-15
PACKAGE LEAFLET: INFORMATION FOR THE USER TRIAPIN 5 MG / 5 MG PROLONGED RELEASE TABLETS ramipril/felodipine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Triapin is and what it is used for 2. What you need to know before you take Triapin 3. How to take Triapin 4. Possible side effects 5. How to store Triapin 6. Contents of the pack and other information 1. WHAT TRIAPIN IS WHAT IT IS USED FOR Triapin 5 mg / 5 mg prolonged release tablets (called also Triapin tablets in this leaflet) contain two medicines called ramipril and felodipine. • Ramipril belongs to a group of medicines called ‘angiotensin converting enzyme inhibitors’ (ACE inhibitors). It works by stopping the production of substances that raise blood pressure and makes your blood vessels relax and widen. • Felodipine belongs to a group of medicines called ‘calcium antagonists’. It makes your blood vessels relax and widen. This helps to lower your blood pressure Triapin tablets are used to treat high blood pressure (hypertension). High blood pressure can mean you are more likely to have problems such as heart disease, kidney disease and stroke. This medicine lowers your blood pressure and lowers the risk of these problems. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TRIAPIN DO NOT TAKE TRIAPIN TABLETS IF: • You are allergic to: • ramipril or any other ACE inhibitor • felodipine or any other calcium antagonists • any of the other ingredients of this medicine (listed in section 6) • You have ever had a serious Read the complete document
Health Products Regulatory Authority 05 May 2022 CRN00CWWV Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Triapin 5 mg/5 mg prolonged release tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg of felodipine and 5 mg of ramipril Excipient(s)with known effect: Each tablet contains lactose anhydrous and macrogolglycerol hydroxystearate (castor oil polyoxyl hydrogenated). For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Prolonged Release Tablet _Product imported from Italy_ Triapin 5mg/5mg tablets are circular (diameter approx 9 mm), reddish-brown coloured, biconvex and engraved H/OE on one side and marked 5 on the other side. 4 CLINICAL PARTICULARS As per PA0540/082/002 5 PHARMACOLOGICAL PROPERTIES As per PA0540/082/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Cellulose microcrystalline Hyprolose Hypromellose Iron oxides E172 Lactose anhydrous Polyethylene Glycol Macrogolglycerol hydroxystearate (castor oil polyoxyl hydrogenated) Maize starch Paraffin Propyl gallate Sodium aluminium silicate Sodium stearyl fumarate Titanium dioxide E171 Health Products Regulatory Authority 05 May 2022 CRN00CWWV Page 2 of 2 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the container and outer carton of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25 ºC. 6.5 NATURE AND CONTENTS OF CONTAINER PVC blisters: 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER IMED Healthcare Ltd. Unit 625 Kilshane Avenue Northwest Business Park Ballycoolin Dublin 15 Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1463/098/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 15 th August 2014 10 DATE OF REVISION OF THE TEXT May 2022 Read the complete document